Radiosurgery and Radiotherapy Robots Market

Radiosurgery and Radiotherapy Robots Market Outlook (2022-2026)

The global radiosurgery and radiotherapy robots market is set to enjoy a valuation of US$ 5.8 billion in 2022. Worldwide sales of radiosurgery and radiotherapy robots are predicted to increase at a steady CAGR of 4.6% to reach a market valuation of US$ 7.1 billion by the end of 2026.

The employment of robots in radiotherapy is being driven by the high requirement for precise and secure delivery of focused high medication doses to the targeted area. The main benefits of radiosurgery and radiotherapy robotic systems are their adaptability in a beam setup and their capacity to account for targeted motion.

Report Attributes	Details
Radiosurgery and Radiotherapy Robots Market Size (2022E)	US$ 5.8 Billion
Forecasted Market Value (2026F)	US$ 7.1 Billion
Global Market Growth Rate (2022-2026)	4.6% CAGR
Key Companies Profiled	Accuray, Inc. Best Theratronics Ltd. BrainLab AG Elekta AB Huiheng Medical, Inc. Masep Medical Science & Technology Development (Shenzhen) Co., Ltd. Neusoft Medical Systems Co., Ltd. Varian Medical Systems, Inc. ViewRay, Inc.

Worldwide Radiosurgery and Radiotherapy Robot Sales Analysis (2017-2021) Vs. Market Forecast Outlook (2022-2026)

In radiotherapy and radiosurgery, robotic systems have been designed for several functions, including the positioning of the beam source, patients, and imaging equipment. Many systems have been approved for use on patients, and some of them are often employed, notably for patient and beam alignment.

Radiosurgery treatment restricts the amount of radiation that healthy tissues are exposed to. This is possible because it enables a very accurate dosage distribution to the patient receiving treatment.

Radiosurgery typically involves the removal of tumour cells using ionised radiation beams and is used to treat cancer. Similar to radiosurgery, radiotherapy treats the tumour with many fractionated doses of radiation over the course of several sittings.

During the projection period of 20220 to 2026, these two therapies are anticipated to become an important means of treating both, malignant and non-cancerous tumours across regions of the world.

According to Fact.MR, a market research and competitive intelligence provider, the global radiosurgery and radiotherapy robots market is currently valued at around US$ 5.8 billion, and is anticipated to expand at a CAGR of 4.6% through the course of the 2022 to 2026 study period.

What Opportunities are Await Radiosurgery and Radiotherapy Robot Manufacturers?

“Improvements in Robotic Medical Equipment Driving Radiosurgery and Radiotherapy Robots Market Growth”

The development of new innovative devices with improved durability has been facilitated by technical advancements in minimally invasive operations. The growth of the radiosurgery and radiotherapy robots market will be aided by the creation of precise and accurate imaging tools for determining tumour size, position, and shape.

High-definition (HD) robotic systems that can provide high-resolution images are becoming more and more popular across the world, which is fostering a positive business environment for vendors with cutting-edge product offerings.

Market players are also making sure that radiosurgery and radiotherapy robots can integrate features such as imaging, treatment planning, quality assurance, dose verification, and post-treatment analysis, which will not only benefit healthcare givers and patients, but also complement overall market growth over the coming years.

Which Regions are Set to be Beneficial for Top Companies in Radiosurgery Robots?

“Rising Medical Problems Leading to Surgical Procedures Driving Sales of Radiosurgery Robotic Systems in North American Region”

The worldwide radiosurgery and radiotherapy robots market is expected to be dominated by the North American region. This is due to the increasing number of minimally invasive surgeries that are being carried out in the region.

Furthermore, the number of patients suffering from neurological problems is increasing rapidly in the region, which further fuels the demand for surgical and rehabilitation robots in healthcare institutions. Due to these reasons, North America currently holds a prominent position in the market for radiosurgery and radiotherapy robots in the world.

The Europe market for radiosurgery and radiotherapy robots is largely driven by developed nations such as Germany, the U.K., and France. The market for radiosurgery and radiotherapy robots in Europe is expected to expand steadily as a result of factors such as increase in the number of people needing diagnoses of brain and spinal tumours, technological advancements in products, rising R&D activities, and growing awareness about the management and treatment of cancer and tumours.

The market in the Asia Pacific region is anticipated to progress rapidly as a result of rising demand from nations such as China, India, and Japan for radiosurgery and radiotherapy robotic systems.

The market for radiosurgery and radiotherapy robots in Asia Pacific is also being driven by an increase in the use of minimally invasive procedures and rising knowledge of cancer therapy among the population.

Country-wise Insights

How is the Market for Radiosurgery and Radiotherapy Robots Progressing in the U.S.?

“Radiosurgery and Radiotherapy Treatments Gaining Popularity Due to Rising Awareness of Benefits of Robotic Surgeries”

The U.S. radiosurgery and radiotherapy robots market was valued at US$ 1.5 billion at the end of 2021. The main factors influencing the rise of robotic systems in radiotherapy and radiosurgery in the country are the surge in the adoption rate of surgical robots and technological advancements in related systems.

Furthermore, the market for radiosurgery and radiotherapy robots will rise due to improvements in the reimbursement structure of the nation, rising awareness about the benefits of robotic surgery, and increasing investments in medical robot research in the United States.

What is the Market Outlook for Radiosurgery and Radiotherapy Treatments in China?

“Rising Awareness about Cancer-related Diseases & Adoption of Minimally Invasive Surgeries Driving Sales of Robotic Radiosurgery Devices in China”

By 2026, the second-largest economy in the world, China, is expected to reach a market valuation of US$ 1.3 billion.

The market for radiosurgery robotic systems in China is primarily driven by the increased adoption of minimally invasive procedures and rising knowledge about cancer therapy among the population. With such a large population, the need for treatment of various diseases also increases, which, in parallel, is driving the need for radiosurgery and radiotherapy devices as well.

Category-wise Analysis

Why are Radiosurgery and Radiotherapy Robotic Systems Most Used in Hospitals?

“High Number of Medical Surgeries Carried Out in Hospitals with Effective Results”

Hospitals are anticipated to hold the largest share of the global market for radiosurgery and radiotherapy robots due to rising medical robot adoption and the high number of robotic surgery procedures that are carried out in hospitals.

The high incidence of cancer and the increase in patients with brain tumours are anticipated to fuel the expansion of the radiosurgery market. Due to the fact that procedures can be carried out faster, more hospitals and doctors across the world that specialize in oncology care are using radiosurgery robotic systems.

Competitive Landscape

Top companies in radiosurgery robots are investing heavily to gain a competitive edge over one another and progress in this market landscape. The market for radiosurgery and radiotherapy robots is expanding into new regions and introducing advanced products at the same time.

New product approvals and launches are both important for market players to enhance their stance as well as drive revenue generation in the market.

• The U.S. Food and Drug Administration approved the novel non-invasive stereotactic radiation system that is used to treat breast cancer, in December 2017, manufactured by the company Xcision Medical Systems, LLC.
• As part of its commitment to provide painless, precise, and non-invasive radiation treatment to thousands of patients being treated for incurable malignant and non-cancerous tumours, Artemis Hospitals introduced North India's first M6 Cyberknife Radiosurgery technology in August 2017.

Key Segments of Radiosurgery and Radiotherapy Robots Industry Research

• By Product :

  • X-ray Based
  • Gamma-ray Based
  • Proton-beam Based

• By End Use :

  • Hospitals
  • Clinics
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA